US launches trade probe into Germany's drug pricing
The US has opened a trade investigation targeting Germany's pharmaceutical sector, reigniting a long-running dispute over drug pricing. Washington argues that German patients benefit from artificially low prices while American patients bear a disproportionate share of the costs of medical innovation. The probe is the latest escalation in a broader transatlantic clash over who should fund pharmaceutical research and development.
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!